Skip to main content

REVIEW article

Front. Immunol.
Sec. Inflammation
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1526786
This article is part of the Research Topic Neuroinflammation: Mechanisms and Therapeutic Interventions View all 3 articles

A New Perspective on the Regulation of Neuroinflammation in Intracerebral hemorrhage: Mechanisms of NLRP3 Inflammasome Activation and Therapeutic Strategies

Provisionally accepted
Kai-Long He Kai-Long He 1Xian Yu Xian Yu 2Lei Xia Lei Xia 1Yan-dong Xie Yan-dong Xie 1En-Bo Qi En-Bo Qi 1Liang Wan Liang Wan 1Xu-Ming Hua Xu-Ming Hua 1Chao-hui Jing Chao-hui Jing 1*
  • 1 Department of Neurosurgery, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • 2 Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

The final, formatted version of the article will be published soon.

    Abstract:Intracerebral hemorrhage (ICH), a specific subtype within the spectrum of stroke disorders, is characterized by its high mortality and significant risk of long-term disability. The initiation and progression of neuroinflammation play a central and critical role in the pathophysiology of ICH. The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, a protein complex involved in initiating inflammation, is the central focus of this article. Microglia and astrocytes play critical roles in the inflammatory damage process associated with neuroinflammation. The NLRP3 inflammasome is expressed within both types of glial cells, and its activation drives these cells toward a pro-inflammatory phenotype, which exacerbates inflammatory damage in the brain. However, the regulatory relationship between these two cell types remains to be explored. Targeting NLRP3 inflammasomes in microglia or astrocytes may provide an effective approach to mitigate neuroinflammation following ICH. This article first provides an overview of the composition and activation mechanisms of the NLRP3 inflammasome. Subsequently, it summarizes recent research findings on novel signaling pathways that regulate NLRP3 inflammasome activity. Finally, we reviewed recent progress in NLRP3 inflammasome inhibitors, highlighting the clinical translation potential of certain candidates. These inhibitors hold promise as innovative strategies for managing inflammation following ICH.

    Keywords: intracerebral hemorrhage, Neuroinflammation, NLRP3 inflammasome, Microglia, astrocyte, Inflammation regulation, clinical translation

    Received: 12 Nov 2024; Accepted: 10 Feb 2025.

    Copyright: © 2025 He, Yu, Xia, Xie, Qi, Wan, Hua and Jing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Chao-hui Jing, Department of Neurosurgery, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.